As the founder and CEO of Octopus Energy, Greg Jackson knows more about Britain's household energy than almost anyone else. Octopus has gone from a challenger energy firm to Britain's biggest ...
Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a trial designed to expand the label of the recently approved drug failed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback